A 30-Week, Forced-titration and Randomised, Crossover, Multicentre, Multinational Trial to Evaluate the Efficacy and Safety of ZD4522 and Atorvastatin in Subjects with Homozygous Familial Hypercholesterolaemia (4522IL/0054): Report of the First 18 Weeks of Treatment (Open label ZD4522 20/40/80 mg, Forced-titration Period)

Study identifier:4522IL/0054

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A 30-Week, Forced-titration and Randomised, Crossover, Multicentre, Multinational Trial to Evaluate the Efficacy and Safety of ZD4522 and Atorvastatin in Subjects with Homozygous Familial Hypercholesterolaemia (4522IL/0054): Report of the First 18 Weeks of Treatment (Open label ZD4522 20/40/80 mg, Forced-titration Period)

Medical condition

dyslipidaemia

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria